this biotech double its price again? 7:02 a.m. July 17,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2013 at 5:50 PM

this biotech double its price again? 7:02 a.m. July 17, 2013 - The Trading Deck
This is a market that wants to go up 12:32 p.m. July 9, 2013 - The Trading Deck
For the medium-term trader, setups galore 10:39 a.m. May 14, 2013 - The Trading Deck
Transparency: Filings reveal funds like Lululemon 11:22 a.m. April 17, 2013 - Insider Monkey
S&P 500 retests the breakout point 10:01 a.m. April 15, 2013 - Michael Ashbaugh
Slow-motion uptrend nears major resistance 10:12 a.m. March 13, 2013 - Michael Ashbaugh
Nasdaq clues suggest more upward valuation 12:46 p.m. March 8, 2013 - The Trading Deck
Stocks poised to top all-time closing high 9:23 a.m. March 5, 2013 - Kate Gibson
J.C. Penney, Impax shares drop after hours 6:46 p.m. March 4, 2013 - Carla Mozee
Santarus Q4 profit triples, offers upbeat view 5:50 p.m. March 4, 2013 - MarketWatch.com
Santarus shares resume trading, rise 12% 4:38 p.m. March 4, 2013 - Carla Mozee
13 stocks for ’13 6:16 p.m. Jan. 3, 2013 - The Trading Deck
Hot stocks to watch 6:31 a.m. Sept. 12, 2012 - MarketWatch.com
U.S. benchmarks violate the 200-day average 10:06 a.m. June 4, 2012 - Michael Ashbaugh
Stocks to watch Monday: AIG, AMD, BP 6:36 a.m. March 5, 2012 - MarketWatch
Medicis, PDL lead drug stocks north 11:47 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Santarus, Pharming tumble on FDA setback 10:11 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Drug indexes diverge; BioSante falls 1:00 p.m. Dec. 28, 2010 - Val Brickates Kennedy

Infinity Shares Up, Post Narrower Loss - Analyst Blog 2:40 p.m. Today - Zacks.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Salix Pharmaceuticals - Fresh Highs On The Santaurus Deal 3:03 p.m. Nov. 11, 2013 - Seeking Alpha
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
Santarus (SNTS) Catches Eye: Stock Surges 37.6% - Analyst Blog 9:14 a.m. Nov. 11, 2013 - Zacks.com
What Does Salix Really Want With Santarus, And Should You Buy? 3:27 a.m. Nov. 11, 2013 - Seeking Alpha
Salix Pharmaceuticals: Santarus Acquisition Fortifies Position In Maturing Gastrointestinal Therapeutics Market 1:42 a.m. Nov. 11, 2013 - Seeking Alpha
BofA Executive Nominated for Under Secretary Of Commerce and 2 Other Hot Stocks to Watch 11:47 a.m. Nov. 8, 2013 - Wall St. Cheat Sheet
Salix Misses On Q3 Earnings; To Buy Santarus - Analyst Blog 11:30 a.m. Nov. 8, 2013 - Zacks.com
The Deal: Salix Pharmaceuticals Buys Santarus for $2.6B 10:50 a.m. Nov. 8, 2013 - TheStreet.com
Santarus (SNTS): Heavy Pre-Market Activity 8:28 a.m. Nov. 8, 2013 - TheStreet.com
UPDATE: Piper Jaffray Downgrades Santarus Following Salix Acquisition Announcement 8:16 a.m. Nov. 8, 2013 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. Nov. 8, 2013 - benzinga.com
Benzinga's Top Downgrades 6:17 a.m. Nov. 8, 2013 - benzinga.com
Santarus Pharming, Announce New Data from Open-Label Repeat Treatment Study with RUCONEST 4:55 a.m. Nov. 8, 2013 - benzinga.com
Salix Pharma to Acquire Santarus 6:18 p.m. Nov. 7, 2013 - TheStreet.com
Salix, Santarus Merging Into Billion-Dollar Drugmaker 5:38 p.m. Nov. 7, 2013 - Investors Business Daily
10-Q: SANTARUS INC 4:39 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Santarus Earnings Should Top 4 Hot Small-Cap Medicals 7:02 a.m. Nov. 7, 2013 - Investors Business Daily

Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena 8:00 a.m. Today - PR Newswire
Morgan & Morgan Announces the Investigation of Santarus, Inc. 4:15 p.m. Nov. 11, 2013 - PR Newswire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 12:31 p.m. Nov. 11, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc. 11:31 a.m. Nov. 11, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Santarus, Inc. 9:10 p.m. Nov. 8, 2013 - PR Newswire
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests 4:36 p.m. Nov. 8, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Santarus, Inc. Stockholders 4:24 p.m. Nov. 8, 2013 - BusinessWire
Law Offices of Howard G. Smith Announces Investigation of Santarus Inc. 1:38 p.m. Nov. 8, 2013 - BusinessWire
Wolf Haldenstein Announces Investigation of Acquisition of Santarus, Inc. 12:36 p.m. Nov. 8, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Santarus, Inc. - SNTS 12:35 p.m. Nov. 8, 2013 - PR Newswire
Santarus Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Salix Pharma 11:32 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Santarus, Inc. (SNTS) Over the Proposed Sale of the Company to Salix Pharmaceuticals Ltd. (SLXP) 11:12 a.m. Nov. 8, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of Santarus, Inc. Buyout Proposal 10:52 a.m. Nov. 8, 2013 - BusinessWire
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd. 10:34 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:33 a.m. Nov. 8, 2013 - BusinessWire
Santarus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Salix Pharmaceuticals, Ltd. 10:17 a.m. Nov. 8, 2013 - PR Newswire
Law Firm Brower Piven Announces Investigation of Santarus, Inc. Proposed Buyout 9:57 a.m. Nov. 8, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with Sale of the Company to Salix Pharmaceuticals, Ltd. 7:18 a.m. Nov. 8, 2013 - BusinessWire
PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST 1:00 a.m. Nov. 8, 2013 - Thomson Reuters ONE
Santarus and Pharming Announce New Data from Open-Label Repeat Treatment Study with RUCONEST (Recombinant Human C1 Esterase Inhibitor) 1:00 a.m. Nov. 8, 2013 - BusinessWire

$SNTS Company News

BHP as an example against contrarian investing 8:42 a.m. Aug. 20, 2013 - The Trading Deck
4 small caps set to surge 10:29 a.m. July 24, 2013 - The Trading Deck
Can

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Davos Healthcare Aims to Revolutionize Hospital Ratings

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

AI-Driven Lumi Transforms Car Dealership Interactions

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Succession Planning in Turmoil: Only 42% Ready

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...